3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
23
Sarcoma
9
Dermatologic
3
Thoracic
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Gastrointestinal
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Genitourinary
1
Endocrine
1
Breast
1
Conditions
Multiple Myeloma
11
Neoplasms, Plasma Cell
5
Waldenstrom Macroglobulinemia
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Lymphoma
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Intraocular Lymphoma
2
Immunoglobulin Light-chain Amyloidosis
2
Immunoblastic Lymphadenopathy
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Oxaliplatin
2
Leucovorin
2
Gemcitabine
2
Fluorouracil
2
Bevacizumab
2
Azacitidine
2
temsirolimus
1
ruxolitinib
1
rucaparib
1
repotrectinib
1
fludarabine
1
ceritinib
1
cc-486
1
abiraterone
1
Uncertainty
1
Thalidomide
1
Temozolomide
1
Suspensions
1
Sorafenib
1
Quality of Life
1
Psychosocial Intervention
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Molecular Diagnostic Techniques
1
Lenalidomide
1
Irinotecan
1
Interleukin-2
1
Injections
1
Immunotherapy
1
INCB057643
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Drug Therapy
×
Plasma cell
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled